Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Alizyme granted exclusive worldwide license to BTG drug delivery technology

July 31, 1998

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

July 28, 1998

Hybridon and Searle extend and expand antisense research collaboration

July 28, 1998

Fuisz and Novopharm enter agreements for CEFORM CR technology

July 28, 1998

Millennium, Wyeth-Ayerst identify another CNS gene target

July 28, 1998

AxyS elucidates 3-D structure of cathepsin S

July 27, 1998

Fuisz and AHP agreement for CEFORM EA technology

July 24, 1998

Genzyme Transgenics and Lilly to develop novel transgenic protein

July 24, 1998

AxyS, Signal announce drug discovery collaboration

July 24, 1998

StressGen establishes multiinstitutional collaboration for stress protein-modulating drugs

July 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...